Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 8.95x is 11% below its estimated 5-year average of 10.10x, near the low end of its estimated 5-year range (6.62x–17.12x).
As of 2026-10-06T15:12:24.230Z. 17.05% above its estimated 12-month average of 7.65x.
Calculation as of: 2026-10-06T15:12:24.230Z.
Quote observation: 2026-10-06T15:10:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a1fa914b4487e4ae5c9b7a635cce1df0c30efb2543a97d65c3cd252c667dccf4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
8.95x
EV/SALES RATIO AVG TTM
7.65x
EV/SALES RATIO AVG 3Y
8.28x
EV/SALES RATIO AVG 5Y
10.10x
EV/SALES RATIO AVG 10Y
12.13x
EV/SALES RATIO AVG 15Y
14.63x
EV/SALES RATIO AVG 20Y
19.71x
CURRENT VS TTM AVG
+17.05%
CURRENT VS 3Y AVG
+8.05%
CURRENT VS 5Y AVG
-11.35%
CURRENT VS 10Y AVG
-26.20%
CURRENT VS 15Y AVG
-38.82%
CURRENT VS 20Y AVG
-54.60%
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 420 covered companies
CURRENT VS SECTOR MEDIAN
+113.10%
vs the sector median at left
Halozyme Therapeutics, Inc.
Market Cap
$12.91B
EV/Sales Ratio
8.95x
TTM Avg
7.65x
3Y Avg
8.28x
5Y Avg
10.10x
Market Cap
$12.78B
EV/Sales Ratio
15.26x
TTM Avg
10.58x
3Y Avg
9.34x
5Y Avg
8.36x
Market Cap
$13.31B
EV/Sales Ratio
21.21x
TTM Avg
34.77x
3Y Avg
175.07x
5Y Avg
160.21x
Market Cap
$12.48B
EV/Sales Ratio
1.82x
TTM Avg
1.82x
3Y Avg
2.49x
5Y Avg
2.97x
Market Cap
$12.47B
EV/Sales Ratio
1.74x
TTM Avg
1.64x
3Y Avg
2.09x
5Y Avg
2.52x
Market Cap
$12.45B
EV/Sales Ratio
0.99x
TTM Avg
0.98x
3Y Avg
0.76x
5Y Avg
0.76x
Market Cap
$12.31B
EV/Sales Ratio
2.42x
TTM Avg
2.32x
3Y Avg
2.35x
5Y Avg
2.17x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | $12.91B | 8.95x | 7.65x | 8.28x | 10.10x |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.78B | 15.26x | 10.58x | 9.34x | 8.36x |
| Tempus AI, Inc. (TEM)vs › | $13.38B | 9.93x | 9.61x | 11.72x | 11.72x |
| Penumbra, Inc. (PEN)vs › | $12.51B | 8.32x | 8.84x | 8.37x | 9.46x |
| BridgeBio Pharma, Inc. (BBIO)vs › | $13.31B | 21.21x | 34.77x | 175.07x | 160.21x |
| ICON Public Limited Company (ICLR)vs › | $12.48B | 1.82x | 1.82x | 2.49x | 2.97x |
| Baxter International Inc. (BAX)vs › | $12.47B | 1.74x | 1.64x | 2.09x | 2.52x |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.45B | 0.99x | 0.98x | 0.76x | 0.76x |
| Encompass Health Corporation (EHC)vs › | $12.31B | 2.42x | 2.32x | 2.35x | 2.17x |
| Ascendis Pharma A/S (ASND)vs › | $14.13B | 11.23x | 17.50x | 23.99x | 205.47x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 9.08x |
| 2026-10-02 | 9.20x |
| 2026-10-01 | 8.98x |
| 2026-09-30 | 9.24x |
| 2026-09-29 | 9.32x |
| 2026-09-28 | 9.42x |
| 2026-09-25 | 9.49x |
| 2026-09-24 | 9.59x |
| 2026-09-23 | 9.38x |
| 2026-09-22 | 9.58x |
| 2026-09-21 | 9.31x |
| 2026-09-18 | 9.38x |
| 2026-09-17 | 9.18x |
| 2026-09-16 | 9.09x |
| 2026-09-15 | 8.93x |
| 2026-09-14 | 9.06x |
| 2026-09-11 | 9.00x |
| 2026-09-10 | 8.99x |
| 2026-09-09 | 9.02x |
| 2026-09-08 | 9.08x |
| 2026-09-04 | 9.22x |
| 2026-09-03 | 9.26x |
| 2026-09-02 | 9.18x |
| 2026-09-01 | 9.04x |
| 2026-08-31 | 8.95x |
| 2026-08-28 | 8.87x |
| 2026-08-27 | 8.98x |
| 2026-08-26 | 8.99x |
| 2026-08-25 | 9.16x |
| 2026-08-24 | 9.11x |
| 2026-08-21 | 9.07x |
| 2026-08-20 | 8.92x |
| 2026-08-19 | 9.03x |
| 2026-08-18 | 8.83x |
| 2026-08-17 | 8.70x |
| 2026-08-14 | 8.38x |
| 2026-08-13 | 8.53x |
| 2026-08-12 | 8.61x |
| 2026-08-11 | 8.67x |
| 2026-08-10 | 8.67x |
| 2026-08-07 | 8.71x |
| 2026-08-06 | 8.20x |
| 2026-08-05 | 8.03x |
| 2026-08-04 | 8.00x |
| 2026-08-03 | 7.92x |
| 2026-07-31 | 7.94x |
| 2026-07-30 | 8.00x |
| 2026-07-29 | 8.00x |
| 2026-07-28 | 8.01x |
| 2026-07-27 | 7.85x |
| 2026-07-24 | 7.89x |
| 2026-07-23 | 7.80x |
| 2026-07-22 | 7.56x |
| 2026-07-21 | 7.62x |
| 2026-07-20 | 7.50x |
| 2026-07-17 | 7.55x |
| 2026-07-16 | 7.53x |
| 2026-07-15 | 7.39x |
| 2026-07-14 | 7.33x |
| 2026-07-13 | 7.42x |
| 2026-07-10 | 7.42x |
| 2026-07-09 | 7.62x |
| 2026-07-08 | 7.76x |
| 2026-07-07 | 7.86x |
| 2026-07-06 | 7.80x |
| 2026-07-02 | 7.69x |
| 2026-07-01 | 7.49x |
| 2026-06-30 | 7.59x |
| 2026-06-29 | 7.50x |
| 2026-06-26 | 7.32x |
| 2026-06-25 | 7.13x |
| 2026-06-24 | 7.01x |
| 2026-06-23 | 6.89x |
| 2026-06-22 | 6.84x |
| 2026-06-18 | 6.80x |
| 2026-06-17 | 6.80x |
| 2026-06-16 | 6.89x |
| 2026-06-15 | 7.02x |
| 2026-06-12 | 6.88x |
| 2026-06-11 | 6.98x |
| 2026-06-10 | 6.96x |
| 2026-06-09 | 7.04x |
| 2026-06-08 | 6.98x |
| 2026-06-05 | 7.04x |
| 2026-06-04 | 7.05x |
| 2026-06-03 | 6.90x |
| 2026-06-02 | 6.62x |
| 2026-06-01 | 6.77x |
| 2026-05-29 | 6.64x |
| 2026-05-28 | 6.77x |
| 2026-05-27 | 6.81x |
| 2026-05-26 | 6.81x |
| 2026-05-22 | 6.78x |
| 2026-05-21 | 6.80x |
| 2026-05-20 | 6.84x |
| 2026-05-19 | 6.81x |
| 2026-05-18 | 6.71x |
| 2026-05-15 | 6.68x |
| 2026-05-14 | 6.85x |
| 2026-05-13 | 6.92x |
| 2026-05-12 | 6.99x |
| 2026-05-11 | 7.03x |
| 2026-05-08 | 6.84x |
| 2026-05-07 | 6.93x |
| 2026-05-06 | 7.03x |
| 2026-05-05 | 6.99x |
| 2026-05-04 | 6.88x |
| 2026-05-01 | 6.83x |
| 2026-04-30 | 6.80x |
| 2026-04-29 | 6.75x |
| 2026-04-28 | 6.82x |
| 2026-04-27 | 6.87x |
| 2026-04-24 | 6.95x |
| 2026-04-23 | 7.05x |
| 2026-04-22 | 7.20x |
| 2026-04-21 | 7.20x |
| 2026-04-20 | 7.30x |
| 2026-04-17 | 7.28x |
| 2026-04-16 | 7.05x |
| 2026-04-15 | 7.17x |
| 2026-04-14 | 7.11x |
| 2026-04-13 | 7.08x |
| 2026-04-10 | 7.15x |
| 2026-04-09 | 7.09x |
| 2026-04-08 | 6.95x |
| 2026-04-07 | 6.80x |
| 2026-04-06 | 6.75x |
| 2026-04-02 | 6.87x |
| 2026-04-01 | 6.95x |
| 2026-03-31 | 6.88x |
| 2026-03-30 | 6.67x |
| 2026-03-27 | 6.63x |
| 2026-03-26 | 6.77x |
| 2026-03-25 | 6.77x |
| 2026-03-24 | 6.67x |
| 2026-03-23 | 6.73x |
| 2026-03-20 | 6.78x |
| 2026-03-19 | 6.77x |
| 2026-03-18 | 6.80x |
| 2026-03-17 | 6.93x |
| 2026-03-16 | 6.86x |
| 2026-03-13 | 6.80x |
| 2026-03-12 | 6.79x |
| 2026-03-11 | 7.04x |
| 2026-03-10 | 7.15x |
| 2026-03-09 | 7.18x |
| 2026-03-06 | 7.11x |
| 2026-03-05 | 7.11x |
| 2026-03-04 | 7.34x |
| 2026-03-03 | 7.29x |
| 2026-03-02 | 7.32x |
| 2026-02-27 | 7.30x |
| 2026-02-26 | 7.27x |
| 2026-02-25 | 7.37x |
| 2026-02-24 | 7.37x |
| 2026-02-23 | 7.39x |
| 2026-02-20 | 7.42x |
| 2026-02-19 | 7.51x |
| 2026-02-18 | 7.61x |
| 2026-02-17 | 8.80x |
| 2026-02-13 | 8.70x |
| 2026-02-12 | 8.45x |
| 2026-02-11 | 8.70x |
| 2026-02-10 | 8.77x |
| 2026-02-09 | 8.80x |
| 2026-02-06 | 8.87x |
| 2026-02-05 | 8.60x |
| 2026-02-04 | 8.55x |
| 2026-02-03 | 8.41x |
| 2026-02-02 | 8.21x |
| 2026-01-30 | 7.94x |
| 2026-01-29 | 8.10x |
| 2026-01-28 | 8.05x |
| 2026-01-27 | 7.79x |
| 2026-01-26 | 7.76x |
| 2026-01-23 | 7.69x |
| 2026-01-22 | 7.89x |
| 2026-01-21 | 7.94x |
| 2026-01-20 | 7.81x |
| 2026-01-16 | 7.89x |
| 2026-01-15 | 7.95x |
| 2026-01-14 | 8.06x |
| 2026-01-13 | 7.93x |
| 2026-01-12 | 8.01x |
| 2026-01-09 | 8.01x |
| 2026-01-08 | 7.98x |
| 2026-01-07 | 8.27x |
| 2026-01-06 | 8.08x |
| 2026-01-05 | 7.89x |
| 2026-01-02 | 7.80x |
| 2025-12-31 | 7.50x |
| 2025-12-30 | 7.54x |
| 2025-12-29 | 7.66x |
| 2025-12-26 | 7.66x |
| 2025-12-24 | 7.61x |
| 2025-12-23 | 7.61x |
| 2025-12-22 | 7.59x |
| 2025-12-19 | 7.51x |
| 2025-12-18 | 7.29x |
| 2025-12-17 | 7.35x |
| 2025-12-16 | 7.22x |
| 2025-12-15 | 7.12x |
| 2025-12-12 | 7.00x |
| 2025-12-11 | 6.97x |
| 2025-12-10 | 7.04x |
| 2025-12-09 | 6.97x |
| 2025-12-08 | 7.07x |
| 2025-12-05 | 7.11x |
| 2025-12-04 | 7.07x |
| 2025-12-03 | 7.24x |
| 2025-12-02 | 7.43x |
| 2025-12-01 | 7.58x |
| 2025-11-28 | 7.91x |
| 2025-11-26 | 8.03x |
| 2025-11-25 | 8.05x |
| 2025-11-24 | 8.16x |
| 2025-11-21 | 7.80x |
| 2025-11-20 | 7.67x |
| 2025-11-19 | 7.79x |
| 2025-11-18 | 7.78x |
| 2025-11-17 | 7.82x |
| 2025-11-14 | 7.77x |
| 2025-11-13 | 7.88x |
| 2025-11-12 | 7.83x |
| 2025-11-11 | 7.78x |
| 2025-11-10 | 7.57x |
| 2025-11-07 | 7.59x |
| 2025-11-06 | 7.61x |
| 2025-11-05 | 7.60x |
| 2025-11-04 | 7.58x |
| 2025-11-03 | 7.39x |
| 2025-10-31 | 7.29x |
| 2025-10-30 | 7.24x |
| 2025-10-29 | 7.30x |
| 2025-10-28 | 7.32x |
| 2025-10-27 | 7.36x |
| 2025-10-24 | 7.39x |
| 2025-10-23 | 7.46x |
| 2025-10-22 | 7.35x |
| 2025-10-21 | 7.46x |
| 2025-10-20 | 7.42x |
| 2025-10-17 | 7.48x |
| 2025-10-16 | 7.46x |
| 2025-10-15 | 7.41x |
| 2025-10-14 | 7.44x |
| 2025-10-13 | 7.31x |
| 2025-10-10 | 7.19x |
| 2025-10-09 | 7.29x |
| 2025-10-08 | 7.30x |
| 2025-10-07 | 7.38x |
| 2025-10-06 | 7.47x |
| 2025-10-03 | 8.49x |
| 2025-10-02 | 8.78x |
| 2025-10-01 | 9.12x |
| 2025-09-30 | 8.95x |
| 2025-09-29 | 8.95x |
| 2025-09-26 | 9.00x |
| 2025-09-25 | 9.02x |
| 2025-09-24 | 9.20x |
| 2025-09-23 | 9.40x |
Showing the most recent 260 of 5,030 data points. The chart above shows the full history.
